These results indicate that IL-6 concentration is strongly associated with the death outcome in patients with visceral leishmaniasis, supporting the hypothesis that inflammation, as measured by IL-6, plays a crucial role in the prognosis of the disease. Here, IL6 is linked to visceral leishmaniasis.